Marksans Pharma Ltd (MARKSANS)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 171.80
% Change: 1.45% (Prev Close: 169.35)

Volume: 9,30,414
% Change: -2.76% (Prev Volume: 9,56,788)

Delivery: 3,98,969
Delivery % : 42.88
% Change: -19.17% (Prev Delivery: 4,93,608)

Turnover: 1,601 Lacs
% Change: -1.46% (Prev Turnover: 1,624)

πŸ’Ή EOD Valuation

P/E Ratio: 22.23
P/B Ratio: 3.16
Market Cap: 7786 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: MARKSANS
Market Cap: 7640 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 358.70
52 Week Low: 165.45

All-Time High: 358.70 Rs.
All-Time Low: 1.27 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-23.35% | -31.33% | -16.48% | -33.78% | 47.93%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 43.87%

Change (3Y | 1Y): -4.38% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 19.89%

Change (3Y | 1Y): 15.85% | -2.30%

DII Holding

DII Holding: 5.50%

Change (3Y | 1Y): 4.56% | 0.95%

Public Holding: 30.74%

🏦 Financial Strength

Debt to Equity: 0.13
Debt: 321.91 Rs. Cr.

Book Value: 54.44 Rs.
Current Ratio: 4.62
Interest Coverage: 32.10
Free Cash Flow: 34.99 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 16.94%

Sales Growth Qtr (YOY | QoQ):
4.97% | -12.49%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
18.25% | 20.72% | 16.94%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 4.90%

Profit Growth Qtr (YOY | QoQ):
-34.29% | -35.85%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
25.78% | 27.23% | 4.90%

EPS Rs.

EPS (TTM): 7.73 Rs.

EPS Qtr (Last Year | Latest):
1.96 Rs. | 1.29 Rs.

EPS Annual (Last Annual | Annual March):
6.92 Rs. | 8.40 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
23.25% | 22.98%

Net Profit Rs. Cr.

Net Profit (TTM): 351.75 Rs. Cr.

Net Profit (Annual - March): 382.62 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
89.07| 90.73 | 58.20

EBITDA Rs. Cr.

EBITDA (Quarter): 105.77 Rs. Cr.
EBITDA (Previous Yr Ql): 143.38 Rs. Cr.

EBITDA (Annual - March): 598.35 Rs. Cr.
EBITDA (Previous Annual): 508.85 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
25.45% | 25.77%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 18.91%

OPM Qtr (Previous | Current):
17.92% | 16.15%

OPM Annual (5 Yrs | Last Yr | March):
20.23% | 21.06% | 20.16%

Return on Equity %

ROE: 16.77%

ROE (5 Yrs | 3 Yrs | Last Yr):
18.53% | 17.01% | 16.46%

Return on Capital Employed %

ROCE: 20.03%

ROCE (5 Yrs | 3 Yrs | Last Yr):
24.61% | 20.73% | 20.61%

Return on Assets %

ROA (TTM): 12.91%

ROA (5 Yrs | 3 Yrs | Last Yr):
15.03% | 13.24% | 12.92%

PEG Ratio: 0.80
Dividend Yield: 0.47%

PE 3 Yrs: 22.83
PE 5 Yrs: 14.59

Dividend Yield: 0.47%

πŸ‘₯ Company

Marksans Pharma Ltd

MARKSANS

Promoter Holding: %